GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Satellos Bioscience Inc (OTCPK:MSCLF) » Definitions » Gross Profit

MSCLF (Satellos Bioscience) Gross Profit : $0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Satellos Bioscience Gross Profit?

Satellos Bioscience's gross profit for the three months ended in Sep. 2024 was $0.00 Mil. Satellos Bioscience's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Satellos Bioscience's gross profit for the three months ended in Sep. 2024 was $0.00 Mil. Satellos Bioscience's Revenue for the three months ended in Sep. 2024 was $0.00 Mil. Therefore, Satellos Bioscience's Gross Margin % for the quarter that ended in Sep. 2024 was N/A%.

Satellos Bioscience had a gross margin of N/A% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage


Satellos Bioscience Gross Profit Historical Data

The historical data trend for Satellos Bioscience's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Satellos Bioscience Gross Profit Chart

Satellos Bioscience Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Gross Profit
-0.04 -0.09 - -

Satellos Bioscience Quarterly Data
Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Satellos Bioscience's Gross Profit

For the Biotechnology subindustry, Satellos Bioscience's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Satellos Bioscience's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Satellos Bioscience's Gross Profit distribution charts can be found below:

* The bar in red indicates where Satellos Bioscience's Gross Profit falls into.



Satellos Bioscience Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Satellos Bioscience's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Satellos Bioscience's Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Satellos Bioscience's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Satellos Bioscience  (OTCPK:MSCLF) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Satellos Bioscience had a gross margin of N/A% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage


Satellos Bioscience Gross Profit Related Terms

Thank you for viewing the detailed overview of Satellos Bioscience's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Satellos Bioscience Business Description

Traded in Other Exchanges
Address
200 Bay Street, Suite 2800, Royal Bank Plaza, South Tower, Toronto, ON, CAN, M5J 2J1
Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.